Left ventricular functional recovery after atrial fibrillation catheter ablation in heart failure: a prediction model
- 30 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 44 (35) , 3327-3335
Abstract
Management of patients with atrial fibrillation (AF) and concomitant heart failure (HF) remains complex. The Antwerp score, based on four parameters [QRS >120 ms (2 points), known aetiology (2 points), paroxysmal AF (1 point), severe atrial dilation (1 point)] adequately estimated the probability of left ventricular ejection fraction (LVEF) recovery after AF ablation in a single-centre cohort. The present study aims to externally validate this prediction model in a large European multi-centre cohort. A total of 605 patients (61.1 ± 9.4 years, 23.8% females, 79.8% with persistent AF) with HF and impaired LVEF (P < .001; Hosmer–Lemeshow P = .29}. Patients with a score < 2 had a 93% probability of LVEF recovery as opposed to only 24% in patients with a score > 3. Responders experienced more often positive ventricular remodelling [odds ratio (OR) 8.91, 95% CI 4.45–17.84, P < .001], fewer HF hospitalizations (OR 0.09, 95% CI 0.05–0.18, P < .001) and lower mortality (OR 0.11, 95% CI 0.04–0.31, P < .001). In this multi-centre study, a simple four-parameter score predicted LVEF recovery after AF ablation in patients with HF and discriminated clinical outcomes. These findings support the use of the Antwerp score to standardize shared decision-making regarding AF ablation referral in future clinical studies. On the upper side, the four variables included in the score and their respective weight is shown. The score was evaluated in 605 heart failure (HF) patients with impaired (P < .001] with a good calibration (P = .296), as shown on the lower right side. In the lower left side, the specific response rate stratified according to the score value is represented.Keywords
Funding Information
- commercial
This publication has 27 references indexed in Scilit:
- Catheter Ablation Versus Best Medical Therapy in Patients With Persistent Atrial Fibrillation and Congestive Heart FailureCirculation: Arrhythmia and Electrophysiology, 2019
- Atrial fibrillation ablation strategies and outcome in patients with heart failure: insights from the German ablation registryClinical Research in Cardiology, 2019
- Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fractionHeart Rhythm, 2018
- Catheter Ablation for Atrial Fibrillation with Heart FailureNew England Journal of Medicine, 2018
- Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic DysfunctionJACC, 2017
- Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted DeviceCirculation, 2016
- The Impact of Known Heart Disease on Long‐Term Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction: A Multicenter International StudyJournal of Cardiovascular Electrophysiology, 2016
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial)Circulation: Arrhythmia and Electrophysiology, 2014
- Catheter Ablation for Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction. A Systematic Review and Meta-AnalysisJournal of Cardiac Failure, 2011